Proliferative Diabetic Retinopathy
102
1
2
59
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
14 trials with published results (14%)
Research Maturity
59 completed trials (58% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.8%
8 terminated out of 102 trials
88.1%
+1.6% vs benchmark
27%
28 trials in Phase 3/4
24%
14 of 59 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 59 completed trials
Clinical Trials (102)
Genetic Markers and Proliferative Diabetic Retinopathy
New Pattern of Retinal Laser Treatment for PDR
UNITY VCS Vitreoretinal Surgery
Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy
Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy
Biological Changes in Fibrovascular Membranes of Patients With Proliferative Diabetic Retinopathy Following Faricimab Injection
Outcomes of Retinal Re-surgeries in Silicone Oil Filled Eyes
Discovering Early Biomarkers in Circulating Endothelial Cells for Diabetes Complications by Single Cell RNA Sequencing
VISUPRIME® Eye Drops
Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy
HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population
Safety and Efficacy of Low-Fluence PRP for PDR
Changes in Vitreous Temperature During Phacoemulsification
Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy.
Intravitreal Bevacizumab for Diabetic Retinopathy
Changes in Macular Thickness After Patterns Scan Laser
Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment
Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy
Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy
Gas Tamponade for Prevention of Postoperative Vitreous Hemorrhage in Diabetics